CANCELLI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 960
EU - Europa 390
AS - Asia 260
AF - Africa 2
OC - Oceania 2
Totale 1.614
Nazione #
US - Stati Uniti d'America 956
CN - Cina 119
DE - Germania 107
UA - Ucraina 96
SG - Singapore 76
IT - Italia 70
FI - Finlandia 30
HK - Hong Kong 30
IE - Irlanda 20
TR - Turchia 20
GB - Regno Unito 16
BE - Belgio 14
IN - India 13
SE - Svezia 13
RU - Federazione Russa 10
CZ - Repubblica Ceca 6
FR - Francia 6
CA - Canada 3
AU - Australia 2
GR - Grecia 2
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
ZA - Sudafrica 1
Totale 1.614
Città #
Fairfield 108
Ann Arbor 81
Ashburn 81
Woodbridge 74
Jacksonville 73
Chandler 67
Singapore 66
Seattle 56
Houston 54
New York 52
Cambridge 50
Beijing 46
Princeton 42
Wilmington 40
Hong Kong 30
Helsinki 27
Brescia 21
Dublin 20
Istanbul 18
Shanghai 16
Brussels 14
Des Moines 13
Boardman 12
Jinan 9
Changsha 8
San Diego 8
Munich 7
Nanjing 7
Brno 6
Bosio 5
Dearborn 5
San Francisco 5
Shenyang 5
Guangzhou 4
Haikou 4
Hebei 4
Los Angeles 4
Pune 4
Bergamo 3
Nanchang 3
Nürnberg 3
Santa Clara 3
Tianjin 3
Falkenstein 2
Hangzhou 2
Kocaeli 2
Leawood 2
Leonberg 2
Melbourne 2
Mumbai 2
Ningbo 2
Norwalk 2
Toronto 2
Verdellino 2
Verona 2
Amman 1
Athens 1
Boston 1
Centurion 1
Grafing 1
Hanover 1
Hillsborough 1
Jiaxing 1
Landshut 1
Lanzhou 1
Lonate Ceppino 1
Markham 1
Mexico City 1
Milan 1
New Delhi 1
Orange 1
Padova 1
Porto 1
Rabat 1
Taiyuan 1
Washington 1
Totale 1.206
Nome #
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 133
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 122
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 121
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 112
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 110
Which sample tube should be used for routine glucose determination ? 108
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 95
Circulating microRNAs and Their Role in Multiple Myeloma 90
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 74
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 73
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 71
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 67
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 59
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 58
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 57
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 57
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 56
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 55
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 53
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19 47
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 46
Totale 1.664
Categoria #
all - tutte 9.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020292 0 0 0 0 19 28 28 28 47 81 28 33
2020/2021332 11 22 10 48 14 42 21 35 31 50 31 17
2021/2022203 16 16 1 16 10 18 10 14 6 35 12 49
2022/2023191 34 8 9 12 17 42 0 19 27 3 8 12
2023/2024248 21 4 27 13 11 72 5 8 39 1 3 44
2024/2025130 12 11 0 68 39 0 0 0 0 0 0 0
Totale 1.664